Dr. Velasquez-Mieyer is Chairman of Lifedoc Health and President of Lifedoc Research. He has an extensive career in population health and translational research, particularly in cardiometabolism. He recieved his medical degree Residency in Internal Medicine from Universidad Central de Venezuela in 1983. He was awarded Harvard University’s Fellowship in Endocrinology and Diabetes, completed at Joslin Diabetes Center and Clinic Laboratories (Boston, MA). In 2005, he co-founded the University of Tennessee Lifestyle Diabetes and Obesity Center (UT-LifeDOC), focusing on clinical management and prevention of Obesity and T2D in youth. In 2009, LifeDOC became a self-standing, private center that has since been consistently recognized by NCQA’s Diabetes Recognition Program (DRP) and PCMH certifications. As of 2021, DarSalud became Lifedoc Health, a 501(c)(3) non-profit organization with Dr. Velasquez as its Chairman. He has been a well-funded investigator in the area of cardiometabolism of youth and minorities. He has been awarded funding from both private and government agencies including the Methodist Research Foundation, Children Foundation, NIDDK, NINR, NCRR as well as several pharmaceutical companies. He has authored/co-authored more than 30 peer-reviewed publications, as well as a book chapter. He has served on the Editorial Board for several medical journals, including Diabetes Care, The American Journal of Medical Science and The Journal of Physiology and Pathophysiology.
Dr. Velasquez-Mieyer is Chairman of Lifedoc Health and President of Lifedoc Research. He has an extensive career in population health and translational research, particularly in cardiometabolism. He recieved his medical degree Residency in Internal Medicine from Universidad Central de Venezuela in 1983. He was awarded Harvard University’s Fellowship in Endocrinology and Diabetes, completed at Joslin Diabetes Center and Clinic Laboratories (Boston, MA). In 2005, he co-founded the University of Tennessee Lifestyle Diabetes and Obesity Center (UT-LifeDOC), focusing on clinical management and prevention of Obesity and T2D in youth. In 2009, LifeDOC became a self-standing, private center that has since been consistently recognized by NCQA’s Diabetes Recognition Program (DRP) and PCMH certifications. As of 2021, DarSalud became Lifedoc Health, a 501(c)(3) non-profit organization with Dr. Velasquez as its Chairman. He has been a well-funded investigator in the area of cardiometabolism of youth and minorities. He has been awarded funding from both private and government agencies including the Methodist Research Foundation, Children Foundation, NIDDK, NINR, NCRR as well as several pharmaceutical companies. He has authored/co-authored more than 30 peer-reviewed publications, as well as a book chapter. He has served on the Editorial Board for several medical journals, including Diabetes Care, The American Journal of Medical Science and The Journal of Physiology and Pathophysiology.